维生素D补充对低维生素D水平哮喘患儿肺功能与哮喘控制的影响
该研究为维生素D儿童哮喘研究(VDKA)的二次分析,纳入176名6–16岁、维生素D水平低于30 ng/ml的哮喘患儿,随机接受每日安慰剂或每日维生素D3 4000 IU联合低剂量丙酸氟替卡松。多变量线性回归显示,维生素D补充与肺功能指标、哮喘控制及哮喘相关生活质量的变化均无显著关联。
要点
- 在维生素D低于30 ng/ml的哮喘患儿中,补充维生素D未显著改善肺功能。
- 维生素D补充未显著改善哮喘控制评分及哮喘相关生活质量。
- 结果不支持为改善上述结局而常规补充维生素D。
核心结论
- 在6–16岁、维生素D水平低于30 ng/ml的哮喘患儿中,维生素D补充与肺功能、哮喘控制及哮喘相关生活质量的变化无显著关联。
- 研究结果不支持推荐补充维生素D以改善该类患儿的肺功能、哮喘控制或哮喘相关生活质量。
研究设计与样本
- 研究为维生素D儿童哮喘研究(VDKA)的二次分析,VDKA为随机、双盲、平行、安慰剂对照临床试验。
- VDKA共随机192名参与者,其中176名纳入肺功能指标(FEV1、FVC、FEV1/FVC)百分比预计值变化及哮喘控制评分的分析。
- 176名参与者中94名年龄≥10岁,同时纳入哮喘相关生活质量评分变化的分析。
- 参与者随机接受每日安慰剂胶囊或每日维生素D3 4000 IU联合低剂量丙酸氟替卡松。
- 多变量线性回归分析调整了研究中心、种族、性别和在研究中的时间。
主要发现
- 维生素D补充与随机化访视至退出访视之间任何结局的变化均无显著关联,包括肺功能指标、哮喘控制和哮喘相关生活质量。
- 分析纳入176名参与者评估肺功能与哮喘控制变化,其中94名评估哮喘相关生活质量变化。
临床怎么用
- 对于维生素D水平低于30 ng/ml的哮喘患儿,不应以改善肺功能、哮喘控制或生活质量为目的常规推荐补充维生素D。
- 临床决策应结合患儿具体情况,不宜依据本研究结果外推至其他维生素D水平或年龄人群。
局限性
- 本研究为VDKA的二次分析,分析人群为192名随机参与者中的176名,部分参与者未纳入分析。
- 哮喘相关生活质量分析仅纳入94名年龄≥10岁的参与者,样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Observational studies have shown that low vitamin D levels are linked to worse lung function and poor asthma control in children with asthma. We hypothesized that vitamin D supplementation would improve function, disease control, and quality of life in children with asthma (ages 6–16 years) and vitamin D levels below 30 ng/ml. We tested this hypothesis in a secondary analysis of data from the Vitamin D Kids Asthma Study (VDKA), a randomized, double-blind, parallel, placebo-controlled clinical trial. Each participant in the VDKA was randomly assigned to either daily placebo capsules or daily vitamin D3 (4,000 IU) plus low-dose inhaled fluticasone propionate. Of the 192 randomized participants, 176 were included in the analysis of change in percent predicted lung function measures (FEV1, FVC, and FEV1/FVC) and asthma control scores. Of these 176 participants, 94 were also included in the analysis of change in asthma-related quality of life scores, as they were 10 years and older. Linear regression was used for the multivariable analysis of vitamin D supplementation and each outcome, which was adjusted for study site, race, sex, and time in the study. In this analysis, vitamin D supplementation was not significantly associated with change in any outcome (lung function measures, asthma control, or asthma-related quality of life) between the randomization and exit visits. Our results do not support recommending vitamin D supplementation to improve lung function, asthma control, or asthma-related quality of life in children with asthma and vitamin D levels below 30 ng/ml. Trial registration: clinicaltrials.gov identifier: NCT02687815
引用
- Han YY, Forno E, Bacharier LB, et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. Eur Respir J. 2021. PMID: 34326185. doi:10.1183/13993003.00989-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。